ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,863,000 | -46.5% | 100,000 | -46.8% | 0.12% | -53.5% |
| Q2 2020 | $9,095,000 | +63.7% | 188,000 | -6.0% | 0.25% | +8.1% |
| Q1 2020 | $5,556,000 | +23.8% | 200,000 | +33.3% | 0.24% | +35.8% |
| Q4 2019 | $4,488,000 | -3.2% | 150,000 | 0.0% | 0.17% | -7.0% |
| Q3 2019 | $4,635,000 | -52.0% | 150,000 | -25.0% | 0.19% | -52.4% |
| Q2 2019 | $9,660,000 | – | 200,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |